Heo Jayoon, Youk Tae-Mi, Seo Kwon-Duk
Department of Hematology-Oncology, National Health Insurance Service Ilsan Hospital, 100 Ilsan-ro, Ilsan-donggu, Goyang 10444, Korea.
Research Institute, National Health Insurance Service Ilsan Hospital, 100 Ilsan-ro, Ilsan-donggu, Goyang 10444, Korea.
J Clin Med. 2021 Jun 9;10(12):2556. doi: 10.3390/jcm10122556.
anemia is known to be a risk factor for developing ischemic stroke in long-term follow-up studies, and it is also known to increase the risk of death in ischemic stroke patients. We aimed to determine the association of anemia with the risk of ischemic stroke and the risk of death after ischemic stroke.
The study included patients from National Health Insurance Service cohort, from January 2005 to December 2015. Anemia patients were defined as those with confirmed diagnostic codes and related medications in the sample cohort, and patients under the age of 18 were excluded. To perform a comparative analysis with the control group, twice as many patients were extracted by propensity score matching. The effects of anemia on the development of ischemic stroke were analyzed.
A total of 58,699 patients were newly diagnosed with anemia during the study period. In anemia group, the rate of ischemic stroke occurring within 1 year was 0.550%, and the rate was 0.272% in the control group. The odds ratio of anemia related to ischemic stroke was 1.602 (95% confidence intervals (CI) 1.363-1.883). During the follow-up period, 175 out of 309 (56.6%) died in anemia group, and 130 out of 314 (41.4%) died in control group. The anemia group showed a higher risk of death than the control group (Hazard ratio 1.509, 95% CI 1.197-1.902).
Analysis of the nationwide health insurance data revealed that anemia is one of the risk factors for the development of ischemic stroke, and also an independent prognostic factor affecting post-stroke mortality.
在长期随访研究中,贫血已知是发生缺血性卒中的一个危险因素,并且也已知会增加缺血性卒中患者的死亡风险。我们旨在确定贫血与缺血性卒中风险以及缺血性卒中后死亡风险之间的关联。
该研究纳入了2005年1月至2015年12月期间国民健康保险服务队列中的患者。贫血患者定义为样本队列中具有确诊诊断编码和相关药物治疗的患者,排除18岁以下的患者。为了与对照组进行比较分析,通过倾向评分匹配提取了两倍数量的患者。分析贫血对缺血性卒中发生的影响。
在研究期间,共有58699例患者新诊断为贫血。贫血组中1年内发生缺血性卒中的发生率为0.550%,对照组为0.272%。与缺血性卒中相关的贫血的优势比为1.602(95%置信区间(CI)1.363 - 1.883)。在随访期间,贫血组309例中有175例(56.6%)死亡,对照组314例中有130例(41.4%)死亡。贫血组的死亡风险高于对照组(风险比1.509,95% CI 1.197 - 1.902)。
对全国健康保险数据的分析表明,贫血是缺血性卒中发生的危险因素之一,也是影响卒中后死亡率的独立预后因素。